Journal of Biochemical Technology

ISSN: 0974-2328
DOI Prefix: 10.51847

Welcome to the Journal of Biochemical Technology, a prestigious international double-blind peer-reviewed journal dedicated to advancing excellence in biochemical, biotechnological, and bioinformatics research with direct applications in biology and medicine. We are committed to maintaining the highest standards of scientific integrity, providing authors with a trusted platform to publish high-quality, impactful research. Our quarterly publication schedule ensures the timely dissemination of important discoveries, promoting the exchange of innovative ideas and developments among researchers worldwide.
Focusing on critical areas such as enzymatic mechanisms, protein engineering, molecular genetics, medical biotechnology, computational biology, genomics, and proteomics, our journal serves as a specialized platform for researchers working at the intersection of biochemistry and biotechnology. The journal is particularly interested in research with biomedical and therapeutic applications, including drug discovery, gene therapy, and cancer research.
Our dedicated editorial team offers full support throughout the submission and publication process, providing guidance on experimental design, data analysis, formatting, and submission procedures. We invite researchers, scholars, and practitioners to contribute to the advancement of biochemical technology, as we collectively work toward solving complex medical and scientific challenges.

Publication Schedule: Quarterly (4 issues per year).

Announcement and Advertisement 
Announcements regarding scientific activities such as conferences, symposium, are published for free. Advertisements can be either published or placed on website as banners.

 

Publisher:

Deniz Publication
Guzelyali Mah. Sahilyolu Cad.Defne Sok. No: 7, 34903 Pendik, Istanbul, Turkey.

Email: [email protected]

Tell: +905344990778

Latest Articles
Chromone–Thiophene Hybrids as Non-Peptidic Inhibitors of SARS-CoV-2 Mpro: Integrated ADME, Docking, and Molecular Dynamics Approach
Chromone–Thiophene Hybrids as Non-Peptidic Inhibitors of SARS-CoV-2 Mpro: Integrated ADME, Docking, and Molecular Dynamics Approach
Written by Mohammed Merzouki   Published on Issue 2 Vol 16, 2025
The SARS‑CoV‑2 main protease (Mpro) is indispensable for viral polyprotein maturation and therefore constitutes a prime antiviral drug target. Guided by drug‑likeness metrics, we designed a focused series of chromone‑thiophene derivatives (M1-M4) that combine a rigid, π‑rich chromone core with a sulfur‑containing hydrophobic anchor. SwissADME calculations revealed that progressive hydroxylation (0-2 OH) endows the series with ideal physicochemical parameters (MW 228-260 g mol⁻¹, cLogP 2.5-3.1, T Read More

Synthesis of ZnO Nanoparticles and Interaction with Protein and Surfactants
Synthesis of ZnO Nanoparticles and Interaction with Protein and Surfactants
Written by Ashoke Hazra   Published on Issue 2 Vol 16, 2025
Zinc oxide nanoparticles (ZnO NPs) have gained significant attention in nanotechnology due to their exceptional physical and chemical properties, including a high surface area, unique optical characteristics, photosensitivity, and biocompatibility. These properties make ZnO NPs highly valuable for various biomedical and technological applications. This study focuses on the synthesis of ZnO NPs using a chemical synthesis approach, ensuring controlled particle formation. The synthesized nanopartic Read More

Medical and Social Aspects of Metabolic Syndrome: Narrative Review and Case Study
Medical and Social Aspects of Metabolic Syndrome: Narrative Review and Case Study
Written by Zhenish Kyzy Asel   Published on Issue 2 Vol 16, 2025
Metabolic syndrome—a cluster of interrelated conditions including obesity, hypertension, dyslipidemia, and insulin resistance—is a key precursor to both type 2 diabetes and cardiovascular disease. In regions with rising burdens of non-communicable diseases, diabetes mellitus has become a leading challenge in clinical management. The narrative review presents a detailed case study of a 64-year-old patient who has insulin-dependent type 2 diabetes mellitus with peripheral neuropathy and nephropath Read More

Issue 3 Volume 16 - 2025